492 related articles for article (PubMed ID: 30355506)
1. Postmenopausal health interventions: Time to move on from the Women's Health Initiative?
Thaung Zaw JJ; Howe PRC; Wong RHX
Ageing Res Rev; 2018 Dec; 48():79-86. PubMed ID: 30355506
[TBL] [Abstract][Full Text] [Related]
2. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
3. Hormone-replacement therapy: current thinking.
Lobo RA
Nat Rev Endocrinol; 2017 Apr; 13(4):220-231. PubMed ID: 27716751
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
[TBL] [Abstract][Full Text] [Related]
5. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
Lukes A
J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
[TBL] [Abstract][Full Text] [Related]
6. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
7. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Salpeter S
Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
[TBL] [Abstract][Full Text] [Related]
8. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
9. What the future holds for women after menopause: where we have been, where we are, and where we want to go.
Lobo RA
Climacteric; 2014 Dec; 17 Suppl 2():12-7. PubMed ID: 25032478
[TBL] [Abstract][Full Text] [Related]
10. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
11. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
[TBL] [Abstract][Full Text] [Related]
12. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
Manson JE; Bassuk SS; Kaunitz AM; Pinkerton JV
Menopause; 2020 Aug; 27(8):918-928. PubMed ID: 32345788
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.
Crawford SL; Crandall CJ; Derby CA; El Khoudary SR; Waetjen LE; Fischer M; Joffe H
Menopause; 2018 Dec; 26(6):588-597. PubMed ID: 30586004
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
[TBL] [Abstract][Full Text] [Related]
16. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
Langer RD
Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
18. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
Derry PS
Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
[TBL] [Abstract][Full Text] [Related]
19. Risks of hormone therapy in the 50-59 year age group.
van de Weijer PH
Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
[TBL] [Abstract][Full Text] [Related]
20. Prevention of diseases after menopause.
Lobo RA; Davis SR; De Villiers TJ; Gompel A; Henderson VW; Hodis HN; Lumsden MA; Mack WJ; Shapiro S; Baber RJ
Climacteric; 2014 Oct; 17(5):540-56. PubMed ID: 24969415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
